Health Care & Life Sciences » Pharmaceuticals | Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.16
Market Cap
CNY6.68 B
Shares Outstanding
595.14 M
Public Float
332.93 M

Profile

Address
North End of Yinchuan Avenue
Shijiazhuang Hebei 050800
China
Employees -
Website http://www.heparin.cn
Updated 07/08/2019
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. Its products include heparin raw materials, heparin sodium injection, enoxaparin sodium API, heparin sodium raw materials, low molecular weight heparin calcium drug, enoxaparin sodium injection, and low molecular weight heparin calcium injection. The company was founded on September 28, 2000 and is headquartered in Shijiazhuang, China.

Financials

View All

Wei Qiao
Chairman-Supervisory Board
Jin Liang Wang
Member-Supervisory Board